Glucagon-like peptide-1 receptor agonists (GLP-1RAs) improve glycaemic control, facilitate clinically meaningful weight loss, improve survival, and reduce the risk of renal failure and major adverse cardiovascular events
WebMD provides reviews from individuals who have taken semaglutide drugs with helpful details on how effective they found them for achieving weight goals, pros and cons of using these medications, potential drug interactions and more
They ask, is Ozempic a GLP-1 agonist
"It's put a lot of resources into marketing the drug, hundreds of millions of dollars to expand the market get new patients for the drug, but it hasn't spent that money on warning patients of the risk of gastroparesis, ileus, small bowel obstruction, and the fact that these injuries can be severe, even if it's in a rare case," Parvin Aminolroaya, Gantt's attorney, told CBS News